R&D Platform

Oncogen’s R&D productivity ranks among the highest for generic companies in Malaysia due to its infrastructure, technical expertise & great teamwork. Our comprehensive development approach covers pre-formulation, early stage formulation and analytical development, QbD based process optimization, scale-up and stability testing, process validation, technology transfer of scalable process and all other associated analytical support services.


By involving our scientists early in the strategic development of all new products, we can develop cost effective products, optimize the process, ensure that regulatory hurdles are minimized and that the most efficient processes are transferred to commercial manufacturing facilities.


We have full capabilities to handle development services for a variety of dosage forms including:

  • Tablets, capsules and powders
  • Liquids, solutions, suspensions and emulsions
  • Lyophilized powders for injection
  • Granules for reconstitution
  • Drug in capsule/vial for clinical trials
  • Other Novel dosage forms (e.g. MUPS, OCAS, DDR, etc.)